Sandy Spring Bank’s Gossamer Bio GOSS Stock Holding History

Sandy Spring Bank’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300	Closed	-$2K	–	1154
2021 Q2	$2K	Buy	+300	New	+$2.6K	﹤0.01%	1073

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sandy Spring Bank's GOSS Position: Q3 2021 in Review

Sandy Spring Bank sold out of Gossamer Bio (GOSS) in Q3 2021, closing a stake of 300 shares — an estimated $2K sold.

Sandy Spring Bank first reported a position in GOSS in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 127 funds tracked by Wall St. Rank hold GOSS as of Q3 2021.

Sandy Spring Bank reported no remaining Gossamer Bio position as of Q3 2021 after selling out during the quarter.
Sandy Spring Bank sold 300 Gossamer Bio shares in Q3 2021, an estimated $2K.
Sandy Spring Bank first reported a position in Gossamer Bio in Q2 2021 and held it in 1 quarter.
Sandy Spring Bank's Gossamer Bio position peaked at $2K in Q2 2021.
127 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2021.

Based on Sandy Spring Bank's 13F filing for Q3 2021, filed 5 Nov 2021.